Outcomes in patients receiving fixed-dosed aflibercept for treatment-naïve neovascular age-related macular degeneration during one year of routine clinical practice. [electronic resource]
Producer: 20200217Description: 430-435 p. digitalISSN:- 2173-5794
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Drug Evaluation
- Female
- Follow-Up Studies
- Humans
- Macula Lutea -- pathology
- Macular Degeneration -- drug therapy
- Male
- Receptors, Vascular Endothelial Growth Factor -- therapeutic use
- Recombinant Fusion Proteins -- therapeutic use
- Retinal Detachment -- drug therapy
- Retinal Hemorrhage -- etiology
- Retinal Pigment Epithelium -- pathology
- Retrospective Studies
- Treatment Outcome
- Visual Acuity
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.